slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 3,601-3,630
Pages 395
Rows per page 30
Slide function
3,601-3,630 of 11,828
03
The slide uses a 3-column layout to map programs to their respective 2020 achievements.Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
09
The chart uses box plots to show median values (389, 171, 127, 112, 99) at different time points.Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
10
The slide uses a heatmap-style visualization to track individual patient progress across three mobility metrics (6MWT, GMFM-D, GMFM-E).Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
The slide uses a line chart to demonstrate clinical efficacy over 12 weeks.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
The slide uses a vertical process flow to map development stages to key de-risking milestones.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
21
The slide highlights positive cognitive signals from a Phase 2 study, specifically emphasizing the efficacy of lower doses of RL-007.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
22
CIAS stands for Cognitive Impairment Associated with Schizophrenia. qEEG is quantitative electroencephalography.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
30
Includes a line chart showing HCQN subscale scores over time and a process diagram for the ongoing trial.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
38
Includes a list of institutional investors at the bottom.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
44
The slide highlights that RL-007 reverses memory deficits at the lowest dose and outperforms the standard of care (Aricept).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
17
The slide uses a combination of bar charts for internal metrics and line charts for external market search trends to demonstrate growth.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Visualization1 hit
36
The chart uses a stacked bar format to show segment contribution to total net sales.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
12
Includes two bar charts showing primary and secondary endpoint results.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Product1 hit
06
Clever Leaves | SPAC Presentation Deck | 16 slidesClever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
10
The slide uses an aerial photograph with annotations to delineate different phases of facility construction.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
13
The slide uses a three-column comparison layout to detail the partnership.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
10
The chart uses a cumulative area plot to visualize franchise growth over time.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
The chart shows AUV growth over time for different franchise cohorts (2014-2019).F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
29
Includes CAGR metrics for pre-COVID and COVID-impacted periods; highlights 2020 as a COVID year.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
34
The slide uses a geographic segmentation to show franchise health metrics and qualitative support initiatives.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
35
Includes social media testimonials and survey statistics.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
37
Includes data on studio reopening counts and specific studio performance examples in Hong Kong and Hendersonville.F45 | SPAC Presentation Deck | 52 slides · F45
Pitch deck Investment bank 1 hit
19
The slide compares tumor volume growth curves (left) with histological H&E staining results (right) to demonstrate efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
20
The slide uses three distinct charts (two line graphs for different tumor types, one for large tumors) and a microscopy image to demonstrate therapeutic efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
25
The slide uses medical imaging to validate the efficacy of the therapeutic agent in diverse solid tumor environments.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
26
The slide demonstrates the stability of the drug's targeting mechanism over time, which is critical for multi-dose therapeutic regimens.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
31
The slide uses a standard preclinical study design (process flow) followed by two line charts comparing treatment efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
27
The slide uses a decomposition of GMV into its two primary drivers: volume (number of orders) and price (AOV).The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit
33
The chart illustrates cohort-based revenue growth over time.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit
34
The slide demonstrates the 'flywheel' effect where dual-role users (buyers/consignors) exhibit significantly higher LTV/BAC ratios.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit